Joosten, Linda P T <br/><br/>
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.  [electronic resource] 

 -  BMJ open  12 2019 
 - e032488 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-6055 
<br/><br/><label>Standard No.: </label>10.1136/bmjopen-2019-032488  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Administration, Oral<br/>Anticoagulants--administration & dosage<br/>Atrial Fibrillation--drug therapy<br/>Frail Elderly<br/>Pragmatic Clinical Trials as Topic<br/>Stroke--prevention & control<br/>Vitamin K--antagonists & inhibitors<br/>Multicenter Studies as Topic